Eric Lefkofsky Hopes to Revolutionize Cancer Technology

Along with his corporate associate Brad Keywell, Eric Lefkofsky has made a fortune by taking numerous startups to public trading status. As one of Chicago’s most prosperous tech founders, he has amassed a sizable fortune that exceeds $1 billion. Despite his success, one of his favorite phrases is “I don’t like starting new companies.”

This changed when his wife was diagnosed with cancer. Along with this life-changing event came the realization cancer patients and doctors lack accessibility to pertinent data and information. That’s how the concept for Tempus was born.

This latest startup of the successful duo uses a data-driven approach to combat cancer. The venture uses genomic sequencing and machine-learning to improve understanding of each patient’s tumor and adapts a treatment regimen best suited for each case. Lefkofsky believes Tempus will serve as a pioneer in the healthcare technology. He foresees a paradigm shift comparable to how Facebook and Google revolutionized the internet.

Eric Lefkofsky is willing to invest countless millions of his own capital into the business and does not need to rely on outside funding. The money pays for a centralized database of patient information and an operating system that lets physicians access and utilize the data. This molecular clinical library allows doctors to learn from prior cancer patients to find individuals with similar clinical profiles. They can use this information to implement treatment options that are more probable to lead to success.

In addition to his Tempus venture, Eric Lefkofsky co-founded Groupon and Uptake Technologies. He also functions as chairman for the former and as a founding partner for Lightbank. Other companies he co-founded include Mediaocean, Echo Global Logistics and InnerWorkings.

In 2006, he established a charitable, private venture with his wife Liz. Appropriately named the Lefkofsky Family Foundation, it was created to support global scientific, educational and scientific causes via grants. Lefkofsky functions as a trustee of the Art Institute of Chicago, World Business Chicago, Lurie Children’s Hospital of Chicago, and the Museum of Science and Industry.

Lefkofsky also serves as a chairman for the Steppenwolf Theatre Company in Chicago. He authored Accelerated Disruption and holds an adjunct professor position at the University of Chicago. Lefkofsky received his juris doctorate degree at the University of Michigan Law School after graduating from the University of Michigan.